AIG
TPTX

American International Group’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

American International Group’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-21,424
Closed -$1.61M – 3068
2022
Q2 		$1.61M Sell
21,424
-1,406
-6% -$62.5K 0.01% 1009
2022
Q1 		$613K Sell
22,830
-1,607
-7% -$54K ﹤0.01% 1611
2021
Q4 		$1.17M Sell
24,437
-730
-3% -$32.6K 0.01% 1331
2021
Q3 		$1.67M Sell
25,167
-598
-2% -$42.6K 0.01% 1139
2021
Q2 		$2.01K Buy
25,765
+4,004
+18% +$296K 0.01% 1116
2021
Q1 		$2.06K Buy
21,761
+57
+0.3% +$6.78K 0.01% 1100
2020
Q4 		$2.65K Buy
21,704
+1,286
+6% +$141K 0.01% 980
2020
Q3 		$1.78M Buy
20,418
+3,389
+20% +$236K 0.01% 996
2020
Q2 		$1.1M Buy
17,029
+634
+4% +$36.6K 0.01% 1178
2020
Q1 		$732K Sell
16,395
-947
-5% -$50.3K ﹤0.01% 1250
2019
Q4 		$1.08M Buy
17,342
+13,149
+314% +$626K ﹤0.01% 1292
2019
Q3 		$158K Sell
4,193
-30
-0.7% -$1.31K ﹤0.01% 2328
2019
Q2 		$172K Buy
+4,223
New +$151K ﹤0.01% 2337

American International Group's TPTX Position: Q3 2022 in Review

American International Group sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 21,424 shares — an estimated $1.61M sold.

American International Group first reported a position in TPTX in Q2 2019 and held it in 13 quarters. The position peaked at $1.78M in Q3 2020. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • American International Group reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • American International Group sold 21,424 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $1.61M.
  • American International Group first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2019 and held it in 13 quarters.
  • American International Group's Turning Point Therapeutics, Inc. Common Stock position peaked at $1.78M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on American International Group's 13F filing for Q3 2022, filed 14 Nov 2022.